![Sijmen de Vries](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sijmen de Vries
Directeur/Membre du Conseil chez
BIODEXA PHARMACEUTICALS PLC
Fortune : - $ au 31/07/2026
Profil
Sijmen de Vries is currently Chief Executive Officer at Pharming Intellectual Property BV, Non-Executive Director at Sylus Pharmaceuticals Ltd. since 2010, Independent Non-Executive Director at Biodexa Pharmaceuticals Plc since 2014, and Finish Partner at BioConnection BV.
Former roles include Chief Executive Officer at Morphochem AG and 4-Antibody AG, Executive Director at Pharming Group NV from 2008 to 2025, and Non-Executive Director at Biodexa Ltd. from 2004 to 2015.
Education includes a doctorate from the University of Amsterdam and an MBA from Ashridge Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Sijmen de Vries
| Sociétés | Poste | Début |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 13/11/2014 |
Sylus Pharmaceuticals Ltd. | Directeur/Membre du Conseil | 21/06/2010 |
Pharming Intellectual Property BV
 Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Directeur Général | - |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Corporate Officer/Principal | - |
Anciens postes connus de Sijmen de Vries
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMING GROUP N.V. | Directeur Général | 04/03/2025 |
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Directeur/Membre du Conseil | 13/03/2015 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Directeur Général | - |
Morphochem AG
 Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Directeur Général | - |
Formation de Sijmen de Vries
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Ashridge Business School
 Ashridge Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Health Technology |
Sylus Pharmaceuticals Ltd. | |
Biodexa Pharmaceuticals Plc
 Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Producer Manufacturing |
